01 1ACS Dobfar S.p.A
02 1Chongqing Carelife Pharmaceutical Co Ltd.
03 1Galenova Inc
04 1Hubei Yitai Pharmaceutical Co., Ltd
05 1LETCO MEDICAL, LLC
06 1Medisca Inc.
07 1Professional Compounding Centers of America
08 1Trifarma S.p.A
09 1Union Quimico Farmaceutica SA (UQUIFA)-Sant Celoni
10 1Xenex Laboratories Inc
11 1Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.
12 2Zhejiang Tiantai Pharmaceutical Co., Ltd.
01 7CLINDAMYCIN PHOSPHATE
02 6Clindamycin Phosphate
01 2Canada
02 5China
03 2Italy
04 1Spain
05 2U.S.A
06 1United Kingdom
NDC Package Code : 52946-0603
Start Marketing Date : 2009-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58598-0003
Start Marketing Date : 2014-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-3171
Start Marketing Date : 2022-03-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0006
Start Marketing Date : 2011-05-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0273
Start Marketing Date : 2013-06-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 46204-0120
Start Marketing Date : 2012-03-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49711-0116
Start Marketing Date : 2009-10-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 67321-302
Start Marketing Date : 2015-02-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 39635-0001
Start Marketing Date : 2014-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 39635-0001
Start Marketing Date : 2024-11-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Clindamycin Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clindamycin Phosphate, including repackagers and relabelers. The FDA regulates Clindamycin Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clindamycin Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clindamycin Phosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clindamycin Phosphate supplier is an individual or a company that provides Clindamycin Phosphate active pharmaceutical ingredient (API) or Clindamycin Phosphate finished formulations upon request. The Clindamycin Phosphate suppliers may include Clindamycin Phosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Clindamycin Phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clindamycin Phosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clindamycin Phosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clindamycin Phosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clindamycin Phosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clindamycin Phosphate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clindamycin Phosphate suppliers with NDC on PharmaCompass.
We have 12 companies offering Clindamycin Phosphate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
